Q1 Interim Report July – September 2020
Opening remarks The new fiscal year started well, with the actual transfer of funds from the European Union Horison 2020 grant, allowing Hamlet Pharma to strengthen its organization by recruiting financial and business development expertise, as well as experts in specific technology areas. The research team of scientists from leading international universities further ensures that the Company will reach important strategic goals. The clinical trials are being resumed, with permission from the Czech authorities. First, a dose-finding study will help to define the optimal dose for